Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Authors
Keywords
-
Journal
SCIENCE
Volume 377, Issue 6606, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-07-05
DOI
10.1126/science.abq0839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2022) Elisabetta Cameroni et al. NATURE
- ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
- (2022) Tyler N. Starr et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020
- (2022) Sergey Alkhovsky et al. Viruses-Basel
- SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
- (2022) Frederick Hansen et al. Cell Reports
- A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
- (2022) Allison J. Greaney et al. PLoS Pathogens
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
- (2021) Yin-Feng Kang et al. ACS Nano
- Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques
- (2021) Gabriel Dagotto et al. JOURNAL OF VIROLOGY
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
- (2021) Tyler N. Starr et al. SCIENCE
- Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
- (2021) Pratima Kumari et al. Viruses-Basel
- A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
- (2021) Tiong Kit Tan et al. Nature Communications
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19
- (2021) Claude Kwe Yinda et al. PLoS Pathogens
- A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
- (2021) Abigail E. Powell et al. ACS Central Science
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
- (2021) Wenjun Wang et al. Cellular & Molecular Immunology
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
- (2021) Alexander A. Cohen et al. PLoS One
- Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia
- (2021) Supaporn Wacharapluesadee et al. Nature Communications
- Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
- (2021) Nicole L. Washington et al. CELL
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Emerging concepts in the science of vaccine adjuvants
- (2021) Bali Pulendran et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses
- (2021) Hong Zhou et al. CELL
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
- (2021) Tyler N. Starr et al. NATURE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
- (2021) Neeltje van Doremalen et al. Science Translational Medicine
- Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
- (2021) Allison J. Greaney et al. Nature Communications
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
- (2021) Claudia A. Jette et al. Cell Reports
- Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
- (2021) Qibin Geng et al. PLoS Pathogens
- SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
- (2021) Frank Konings et al. Nature Microbiology
- Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
- (2021) Deborah L. Burnett et al. IMMUNITY
- Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
- (2021) Caifang Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
- (2021) Ryo Shinnakasu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus
- (2021) Wenjuan Dong et al. JOURNAL OF VIROLOGY
- A novel SARS-CoV-2 related coronavirus in bats from Cambodia
- (2021) Deborah Delaune et al. Nature Communications
- SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
- (2021) M. Gordon Joyce et al. Cell Reports
- Omicron variant and booster COVID-19 vaccines
- (2021) Talha Khan Burki Lancet Respiratory Medicine
- Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
- (2021) Harry Kleanthous et al. npj Vaccines
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- Antigenic Variability
- (2020) Alexander I. Mosa Frontiers in Immunology
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
- (2020) Hejun Liu et al. IMMUNITY
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Human Coronavirus: Host-Pathogen Interaction
- (2019) To Sing Fung et al. Annual Review of Microbiology
- Approaching infinite affinity through engineering of peptide–protein interaction
- (2019) Anthony H. Keeble et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination
- (2018) Theodora Ulli Jordanka Bruun et al. ACS Nano
- Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
- (2016) Karl D. Brune et al. Scientific Reports
- Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
- (2013) A. P. West et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
- (2012) B. Zakeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0
- (2010) Stéphane Guindon et al. SYSTEMATIC BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now